PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This statement includes:
- limitations of SARS-CoV-2 rapid antigen tests